Know Cancer

or
forgot password
  • cancer clinical trials in bozeman, MT

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Internal Medicine Associates of Bozeman

    Trial Locations
    Internal Medicine Associates of Bozeman
    Bozeman Deaconess Hospital
    Lymphoma
    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Prostate Cancer
    Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Internal Medicine of Bozeman
    Adult Acute Lymphoblastic Leukemia in Remission
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Internal Medicine of Bozeman
    Bozeman, Montana 59715
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    Internal Medicine Associates of Bozeman

    Trial Locations
    Internal Medicine Associates of Bozeman
    Bozeman Deaconess Hospital
    Multiple Myeloma
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Bozeman Deaconess Cancer Center

    Trial Locations
    Bozeman Deaconess Cancer Center
    Internal Medicine of Bozeman
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Internal Medicine of Bozeman
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Internal Medicine of Bozeman
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
    Internal Medicine Associates of Bozeman

    Trial Locations
    Internal Medicine Associates of Bozeman
    Bozeman Deaconess Hospital
    Breast Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Internal Medicine of Bozeman
    Bozeman, Montana 59715
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Recurrent Mantle Cell Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Internal Medicine of Bozeman
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer